Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences

다국어 초록 (Multilingual Abstract)

Baseline magnetic resonance imaging (MRI) has become the primary staging modality for surgical plans and stratification of patient populations for more efficient neoadjuvant treatment. Patients who exhibit a complete response to chemoradiotherapy (CRT) may achieve excellent local tumor control and better quality of life with organ-preserving treatments such as local excision or even watch-and-wait management. Therefore, the evaluation of tumor response is a key factor for determining the appropriate treatment following CRT. Although post-CRT MRI is generally accepted as the first-choice method for evaluating treatment response after CRT, its application in the clinical decision process is not fully validated. In this review, we will discuss various oncologic treatment options from radical surgical technique to organ-preservation strategies for achieving better cancer control and improved quality of life following CRT. In addition, the current status of post-CRT MRI in restaging rectal cancer as well as the main imaging features that should be evaluated for treatment planning will also be described for the tailored treatment.

참고문헌 (Reference)

1 Nagtegaal ID, "What is the role for the circumferential margin in the modern treatment of rectal cancer?" 26 : 303-312, 2008

2 Maas M, "Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer" 29 : 4633-4640, 2011

3 Lahaye MJ, "USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria" 246 : 804-811, 2008

4 Prall F, "Tumour regression and mesorectal lymph node changes after intensified neoadjuvant chemoradiation for carcinoma of the rectum" 114 : 201-210, 2006

5 Goodman KA, "Timing is everything: what is the optimal duration after chemoradiation for surgery for rectal cancer?" 34 : 3724-3728, 2016

6 Chand M, "The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer" 261 : 473-479, 2015

7 Kim S, "T2-weighted signal intensity-selected volumetry for prediction of pathological complete response after preoperative chemoradiotherapy in locally advanced rectal cancer" 28 : 5231-5240, 2018

8 Kluza E, "T2 weighted signal intensity evolution may predict pathological complete response after treatment for rectal cancer" 23 : 253-261, 2013

9 Kim NK, "Surgical treatment of colorectal cancer: Asian perspectives on optimization and standardization" Springer Singapore 2018

10 Akiyoshi T, "Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging" 21 : 189-196, 2014

11 Adam IJ, "Role of circumferential margin involvement in the local recurrence of rectal cancer" 344 : 707-711, 1994

12 Barbaro B, "Restaging locally advanced rectal cancer with MR imaging after chemoradiation therapy" 30 : 699-716, 2010

13 Heald RJ, "Recurrence and survival after total mesorectal excision for rectal cancer" 1 : 1479-1482, 1986

14 Madbouly KM, "Recurrence after transanal excision of T1 rectal cancer: should we be concerned?" 48 : 711-719, 2005

15 Park SH, "Rectal mucinous adenocarcinoma: MR imaging assessment of response to concurrent chemotherapy and radiation therapy-A hypothesis-generating study" 285 : 124-133, 2017

16 Curvo-Semedo L, "Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusionweighted MR imaging" 260 : 734-743, 2011

17 Glynne-Jones R, "Rectal cancer--the times they are a-changing" 13 : 651-653, 2012

18 Gerard JP, "Radiotherapy alone in the curative treatment of rectal carcinoma" 4 : 158-166, 2003

19 Cummings BJ, "Radical external beam radiation therapy for adenocarcinoma of the rectum" 26 : 30-36, 1983

20 Battersby NJ, "Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study" 263 : 751-760, 2016

21 Liang P, "Prognostic significance of immunohistochemically detected blood and lymphatic vessel invasion in colorectal carcinoma: its impact on prognosis" 14 : 470-477, 2007

22 Sauer R, "Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median followup of 11 years" 30 : 1926-1933, 2012

23 Yamada K, "Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer" 88 : 988-993, 2001

24 Kusters M, "Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial" 36 : 470-476, 2010

25 Habr-Gama A, "Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy" 10 : 1319-1328, 2006

26 van der Paardt MP, "Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis" 269 : 101-112, 2013

27 Oh HK, "Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study" 21 : 2280-2287, 2014

28 Borschitz T, "Neoadjuvant chemoradiation and local excision for T2-3rectal cancer" 15 : 712-720, 2008

29 Brown G, "Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison" 227 : 371-377, 2003

30 Tepper JE, "Minimizing therapy and maximizing outcomes in rectal cancer" 29 : 4604-4606, 2011

31 Vliegen RF, "Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction" 246 : 454-462, 2008

32 Jang JK, "Magnetic resonance tumour regression grade and pathological correlates in patients with rectal cancer" 105 : 1671-1679, 2018

33 Bhoday J, "Magnetic resonance tumor regression grade and residual mucosal abnormality as predictors for pathological complete response in rectal cancer postneoadjuvant chemoradiotherapy" 59 : 925-933, 2016

34 Patel UB, "Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes:MERCURY experience" 29 : 3753-3760, 2011

35 Lee ES, "Magnetic resonance imaging-detected extramural venous invasion in rectal cancer before and after preoperative chemoradiotherapy: diagnostic performance and prognostic significance" 28 : 496-505, 2018

36 Costa-Silva L, "Magnetic resonance imaging of rectal cancer" 21 : 385-408, 2013

37 Kulkarni T, "Magnetic resonance imaging in rectal cancer downstaged using neoadjuvant chemoradiation: accuracy of prediction of tumour stage and circumferential resection margin status" 10 : 479-489, 2008

38 Beets-Tan RGH, "Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting" 28 : 1465-1475, 2018

39 Lambregts DM, "MRI and diffusion-weighted MRI volumetry for identification of complete tumor responders after preoperative chemoradiotherapy in patients with rectal cancer: a Bi-institutional validation study" 262 : 1034-1039, 2015

40 Patel UB, "MRI after treatment of locally advanced rectal cancer:how to report tumor response--the MERCURY experience" 199 : W486-W495, 2012

41 Engelen SM, "MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision" 53 : 979-986, 2010

42 Perez RO, "Lymph node size in rectal cancer following neoadjuvant chemoradiation--can we rely on radiologic nodal staging after chemoradiation?" 52 : 1278-1284, 2009

43 Nagtegaal ID, "Low rectal cancer: a call for a change of approach in abdominoperineal resection" 23 : 9257-9264, 2005

44 Paty PB, "Long-term results of local excision for rectal cancer" 236 : 522-529, 2002

45 van der Valk MJM, "Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD):an international multicentre registry study" 391 : 2537-2545, 2018

46 Maas M, "Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer:a pooled analysis of individual patient data" 11 : 835-844, 2010

47 Kim SH, "Locally advanced rectal cancer: added value of diffusionweighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy" 253 : 116-125, 2009

48 Park MJ, "Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy" 260 : 771-780, 2011

49 Lahaye MJ, "Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?" 252 : 81-91, 2009

50 Francois Y, "Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer:the Lyon R90-01 randomized trial" 17 : 23962402-, 1999

51 Chand M, "Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer" 110 : 19-25, 2014

52 Ale Ali H, "Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications" 44 : 1-10, 2019

53 Koh DM, "Evaluating mesorectal lymph nodes in rectal cancer before and after neoadjuvant chemoradiation using thinsection T2-weighted magnetic resonance imaging" 71 : 456-461, 2008

54 KSAR Study Group for Rectal Cancer, "Essential Items for Structured Reporting of Rectal Cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology" 대한영상의학회 18 (18): 132-151, 2017

55 Lefevre JH, "Effect of interval (7 or 11 weeks)between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6)" 34 : 3773-3780, 2016

56 Duldulao MP, "Distribution of residual cancer cells in the bowel wall after neoadjuvant chemoradiation in patients with rectal cancer" 56 : 142-149, 2013

57 Kuvshinoff B, "Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1cm distal margins sufficient?" 8 : 163-169, 2001

58 Lambregts DM, "Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study" 18 : 2224-2231, 2011

59 Kim JG, "Diagnostic performance of MRI for prediction of candidates for local excision of rectal cancer (ypT0-1N0) after neoadjuvant chemoradiation therapy" 44 : 471-477, 2016

60 MERCURY Study Group, "Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study" 333 : 779-, 2006

61 Shihab OC, "Defining the surgical planes on MRI improves surgery for cancer of the low rectum" 10 : 1207-1211, 2009

62 Park IJ, "Current issues in locally advanced colorectal cancer treated by preoperative chemoradiotherapy" 20 : 2023-2029, 2014

63 Yu HC, "Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis" 29 : 183-191, 2014

64 Patel UB, "Comparison of magnetic resonance imaging and histopathological response to chemoradiotherapy in locally advanced rectal cancer" 19 : 2842-2852, 2012

65 Sclafani F, "Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer" 117 : 1478-1485, 2017

66 Kim KH, "Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia" 46 : 316-322, 2016

67 Maas M, "Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organsaving treatment" 22 : 3873-3880, 2015

68 김남규, "Anatomic Basis of Sharp Pelvic Dissection for Curative Resection of Rectal Cancer" 연세대학교의과대학 46 (46): 737-749, 2005

69 Smith JJ, "Advances and challenges in treatment of locally advanced rectal cancer" 33 : 1797-1808, 2015

70 Kim SH, "Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer" 29 : 1093-1101, 2009

71 Taylor FG, "A systematic approach to the interpretation of preoperative staging MRI for rectal cancer" 191 : 1827-1835, 2008

72 Battersby NJ, "A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial" 18 : 394-, 2017

73 García-Aguilar J, "A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision" 46 : 298-304, 2003